HLYK HealthLynked Corporation (QB)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * DENT MICHAEL T	2. Issuer Name and Ticker or Trading Symbol HealthLynked Corp [ HLYK ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chief Executive Officer
(Last)          (First)          (Middle) 1726 MEDICAL BLVD., SUITE 101	3. Date of Earliest Transaction (MM/DD/YYYY) 8/24/2020
(Street) NAPLES, FL 34110 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	8/24/2020		J(1)		24522727	A	$0.12	74376367	I	Held by trust (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Convertible Preferred Stock	(3)	8/24/2020		J (1)		2750000		12/31/2022	(4)	Common Stock	13750000	$1.09	2750000	I	Held by trust (5)

Explanation of Responses:
(1)	The reporting person received the Series B Convertible Preferred Stock in consideration for a Internal Revenue Code Section 351 contribution transaction with the issuer.
(2)	Held beneficially by the Mary S. Dent Gifting Trust dated January 31, 2006. The reporting person is the trustee of such trust.
(3)	Each share of Series B Convertible Preferred Stock is convertible into five (5) shares of common stock.
(4)	The Series B Convertible Preferred Stock has no expiration date.
(5)	Held beneficially by the Michael Thomas Dent Declaration of Trust dated March 23, 1998, as amended.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
DENT MICHAEL T 1726 MEDICAL BLVD., SUITE 101 NAPLES, FL 34110	X		Chief Executive Officer

Signatures
/s/ Michael Dent		8/26/2020
**Signature of Reporting Person		Date